Here are five things to know.
1. His retirement will end a 19-year career at the company. Mr. Caruso came to the company after Johnson & Johnson acquired Centocor.
2. Mr. Caruso became CFO in 2007. During his tenure, J&J completed a $30 billion acquisition of Actelion; $21.3 billion acquisition of Synthes; and $16.6 billion acquisition of Pfizer Consumer Healthcare.
3. Joseph Wolk, vice president of investor relations, is slated to assume Mr. Caruso’s role.
4. Mr. Wolk has been with J&J for 19 years. He has worked alongside the company’s finance leadership team since 2004.
5. Previously, Mr. Wolk served as CFO of the Janssen Pharmaceutical Companies of J&J.
More articles on devices and implants:
Exactech receives FDA clearance for hip replacement polyethylene liners — 3 insights
Centinel Spine, PGA Tour winner Brian Gay team up — 5 highlights
10 things to know about K2M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
